Literature DB >> 15740778

Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice.

Mustafa Akhisaroglu1, Murat Kurtuncu, Hari Manev, Tolga Uz.   

Abstract

Dopaminergic drugs, including the D2/D3 agonist quinpirole, produce lasting changes in the brain that lead to altered behavioral responses. The action of these drugs is dosing time-dependent; in fruit flies, behavioral response to quinpirole shows a marked circadian variability. Here we demonstrate diurnal rhythm-dependent variations both in quinpirole-induced locomotor behaviors and in striatal D2 and D3 protein levels in mice. We found opposing diurnal rhythms in striatal D2 and D3 protein levels, resulting in a high D2/D3 ratio during the day and a low D2/D3 ratio at night. Protracted quinpirole treatment differentially altered striatal D2/D3 rhythms depending on the time of injection (i.e., day or night). When quinpirole-induced locomotor activity was analyzed for 90 min, we found hypomotility after the first day or nighttime drug injection. By the seventh injection, daytime quinpirole treatment produced clear hyperactivity while nighttime quinpirole treatment continued to induce a significant initial hypoactivity followed by a hyperactivity period. Our data indicate that quinpirole-induced long-term alterations in the brain include dosing time-dependent changes in dopamine receptor rhythms. Therefore, we propose that diurnal mechanisms, which participate in drug-induced long-term changes in the dopamine system, are important for the development of dopaminergic behaviors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15740778     DOI: 10.1016/j.pbb.2004.11.016

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  15 in total

Review 1.  Circadian genes, rhythms and the biology of mood disorders.

Authors:  Colleen A McClung
Journal:  Pharmacol Ther       Date:  2007-02-28       Impact factor: 12.310

2.  Dopamine receptor-mediated regulation of neuronal "clock" gene expression.

Authors:  M Imbesi; S Yildiz; A Dirim Arslan; R Sharma; H Manev; T Uz
Journal:  Neuroscience       Date:  2008-11-05       Impact factor: 3.590

Review 3.  Circadian clock genes: effects on dopamine, reward and addiction.

Authors:  Puja K Parekh; Angela R Ozburn; Colleen A McClung
Journal:  Alcohol       Date:  2015-01-08       Impact factor: 2.405

4.  Direct regulation of diurnal Drd3 expression and cocaine reward by NPAS2.

Authors:  Angela R Ozburn; Edgardo Falcon; Alan Twaddle; Alexandria L Nugent; Andrea G Gillman; Sade M Spencer; Rachel N Arey; Shibani Mukherjee; James Lyons-Weiler; David W Self; Colleen A McClung
Journal:  Biol Psychiatry       Date:  2014-08-13       Impact factor: 13.382

5.  Free-running rhythms of cocaine self-administration in rats held under constant lighting conditions.

Authors:  Caroline E Bass; Heiko T Jansen; David C S Roberts
Journal:  Chronobiol Int       Date:  2010-05       Impact factor: 2.877

Review 6.  Zebrafish models in neuropsychopharmacology and CNS drug discovery.

Authors:  Kanza M Khan; Adam D Collier; Darya A Meshalkina; Elana V Kysil; Sergey L Khatsko; Tatyana Kolesnikova; Yury Yu Morzherin; Jason E Warnick; Allan V Kalueff; David J Echevarria
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

7.  BTBD9 and dopaminergic dysfunction in the pathogenesis of restless legs syndrome.

Authors:  Shangru Lyu; Atbin Doroodchi; Hong Xing; Yi Sheng; Mark P DeAndrade; Youfeng Yang; Tracy L Johnson; Stefan Clemens; Fumiaki Yokoi; Michael A Miller; Rui Xiao; Yuqing Li
Journal:  Brain Struct Funct       Date:  2020-05-28       Impact factor: 3.270

8.  Increased synaptic dopamine in the putamen in restless legs syndrome.

Authors:  Christopher J Earley; Hiroto Kuwabara; Dean F Wong; Charlene Gamaldo; Rachel E Salas; James R Brašić; Hayden T Ravert; Robert F Dannals; Richard P Allen
Journal:  Sleep       Date:  2013-01-01       Impact factor: 5.849

Review 9.  Circadian rhythms and addiction: mechanistic insights and future directions.

Authors:  Ryan W Logan; Wilbur P Williams; Colleen A McClung
Journal:  Behav Neurosci       Date:  2014-04-14       Impact factor: 1.912

10.  Melatonin receptors limit dopamine reuptake by regulating dopamine transporter cell-surface exposure.

Authors:  Abla Benleulmi-Chaachoua; Alan Hegron; Marine Le Boulch; Angeliki Karamitri; Marta Wierzbicka; Victoria Wong; Igor Stagljar; Philippe Delagrange; Raise Ahmad; Ralf Jockers
Journal:  Cell Mol Life Sci       Date:  2018-07-24       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.